Literature DB >> 21004764

The petit mal epilepsies; their treatment with tridione.

W G LENNOX.   

Abstract

Entities:  

Keywords:  EPILEPSY/therapy

Mesh:

Substances:

Year:  1945        PMID: 21004764     DOI: 10.1001/jama.1945.02860500001001

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  27 in total

1.  [THE AKINETIC PETIT MAL. II. FORMS OF DEVELOPMENT AND RELATIONS TO THE LIGHTNING-ROD-SALAAM CONVULSIONS AND ABSENCES].

Authors:  H DOOSE
Journal:  Arch Psychiatr Nervenkr       Date:  1964-10-07

2.  [The problem of oral-petit mal].

Authors:  E NIEDERMEYER
Journal:  Dtsch Z Nervenheilkd       Date:  1955

3.  [EEG changes in psychomotor epilepsy].

Authors:  W CHRISTIAN
Journal:  Dtsch Z Nervenheilkd       Date:  1962

4.  [On the differentiation of psychomotor attacks in clinical forms].

Authors:  O HALLEN
Journal:  Dtsch Z Nervenheilkd       Date:  1962

5.  [Catamnestic studies & EEG in pyknolepsy].

Authors:  G PAAL
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1957

6.  [Oral petit mal; description and analysis of uncinate and psychomotor fits as epileptic equivalents].

Authors:  O HALLEN
Journal:  Dtsch Z Nervenheilkd       Date:  1954

Review 7.  Discovery of antiepileptic drugs.

Authors:  Misty Smith; Karen S Wilcox; H Steve White
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 8.  Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

Authors:  Melissa Barker-Haliski; H Steve White
Journal:  Neuropharmacology       Date:  2019-08-27       Impact factor: 5.250

Review 9.  The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models.

Authors:  H S White; M Johnson; H H Wolf; H J Kupferberg
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.